Emergent BioSolutions
EBS
#6775
Rank
NZ$1.13 B
Marketcap
NZ$21.20
Share price
-1.78%
Change (1 day)
25.39%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: NZ$1.13 Billion

As of January 2026 Emergent BioSolutions has a market cap of NZ$1.13 Billion. This makes Emergent BioSolutions the world's 6775th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.13 B-1.21%
2025NZ$1.14 B44.11%
2024NZ$0.79 B303.52%
2023NZ$0.19 B-78.78%
2022NZ$0.92 B-72.9%
2021NZ$3.42 B-47.98%
2020NZ$6.58 B58.91%
2019NZ$4.14 B-8.47%
2018NZ$4.52 B38.6%
2017NZ$3.26 B70.04%
2016NZ$1.91 B-16.65%
2015NZ$2.30 B75.78%
2014NZ$1.31 B27.91%
2013NZ$1.02 B46.5%
2012NZ$0.69 B-9.84%
2011NZ$0.77 B-27.14%
2010NZ$1.06 B84.56%
2009NZ$0.57 B-57.15%
2008NZ$1.34 B585.02%
2007NZ$0.19 B-55.04%
2006NZ$0.43 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Emergent BioSolutions was reported to be:

NZ$1.13 Billion
by Nasdaq info icon info icon
NZ$1.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
NZ$471.13 B 41,547.49%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.82 B-27.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$175.71 B 15,432.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$3.00 B 165.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$249.14 B 21,923.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$64.90 B 5,637.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
NZ$24.07 M-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA